Intervention not reported
Dual‐mobility total hip arthroplasty (No direct evidence, indirect evidence only) · older adults (> 60 years of age) with intracapsular hip fractures; most fractures in the included studies were displaced
It is very uncertain whether the intervention changes dual‐mobility total hip arthroplasty (No direct evidence, indirect… (very low certainty).
1 finding from 1 review
RR 0.64 [0.02, 17.67]
Studies not reported
Very low
Intervention not reported
Dual‐mobility total hip arthroplasty (No direct evidence, indirect evidence only) · older adults (> 60 years of age) with intracapsular hip fractures; most fractures in the included studies were displaced
It is very uncertain whether the intervention changes dual‐mobility total hip arthroplasty (No direct evidence, indirect… (very low certainty).
1 finding from 1 review
RR 1.07 [0.37, 3.14]
Studies not reported
Very low
Muscle soreness · mainly physically active individuals1 partaking in exercise2 designed to produce delayed onset muscle soreness
Summary of findings: antioxidants showed no clear difference in muscle soreness compared with placebo (low certainty).
5 findings from 1 review
no estimate extracted
21 studies · 525 participants
Low
no estimate extracted
41 studies · 936 participants
Moderate
no estimate extracted
45 studies · 1047 participants
Low
Show 2 more findings
Subjective recovery · mainly physically active individuals1 partaking in exercise2 designed to produce delayed onset muscle soreness
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · mainly physically active individuals1 partaking in exercise2 designed to produce delayed onset muscle soreness
1 finding from 1 review
Intervention not reported
Subjective knee score ‐ KOOS‐4 score (mean score of 4 components) at 2 years: score from 0 (extreme symptoms) to 100 (no symptoms) · Adults with acute anterior cruciate ligament (ACL) injuries (young, active individuals)
1 finding from 1 review
Intervention not reported
Serious adverse events (such as donor site morbidity, failure of graft including re‐rupture) at 2 years · Adults with acute anterior cruciate ligament (ACL) injuries (young, active individuals)
1 finding from 1 review
Intervention not reported
Treatment failure (graft rupture or ACL reconstruction) at 2 years5 · Adults with acute anterior cruciate ligament (ACL) injuries (young, active individuals)
The intervention may leads to lower treatment failure (graft rupture or ACL reconstruction) at 2 years5 (low certainty).
1 finding from 1 review
Intervention not reported
Treatment failure (meniscal surgery) at 5 years5,7 · Adults with acute anterior cruciate ligament (ACL) injuries (young, active individuals)
The intervention showed no clear difference in treatment failure (meniscal surgery) at 5 years5,7 (low certainty).
1 finding from 1 review
Intervention not reported
General health‐related quality of life: SF‐36 physical component score (range 0 to 100; higher score = better health state) at 2 years · Adults with acute anterior cruciate ligament (ACL) injuries (young, active individuals)
1 finding from 1 review
Intervention not reported
Return to activity or level of sport at 2 years · Adults with acute anterior cruciate ligament (ACL) injuries (young, active individuals)
The intervention showed no clear difference in return to activity or level of sport at 2 years (low certainty).
1 finding from 1 review
Intervention not reported
Osteoarthritis at 5 years · Adults with acute anterior cruciate ligament (ACL) injuries (young, active individuals)
It is very uncertain whether the intervention changes osteoarthritis at 5 years (very low certainty).
1 finding from 1 review
Intervention not reported
Patient‐reported functional outcomes (pooled data) · individuals more than 18 years old with distal tibial metaphyseal fractures
It is very uncertain whether the intervention changes patient‐reported functional outcomes (pooled data) (very low certainty).
1 finding from 1 review
Intervention not reported
Need for a secondary/revision operation or substantive physiotherapy for adverse outcomes (e.g. non‐union, malunion or infection) · individuals more than 18 years old with distal tibial metaphyseal fractures
It is very uncertain whether the intervention changes need for a secondary/revision operation or substantive physiotherapy… (very low certainty).
1 finding from 1 review
Intervention not reported
Symptomatic non‐union or malunion, including limping 1 year · individuals more than 18 years old with distal tibial metaphyseal fractures
It is very uncertain whether the intervention changes symptomatic non‐union or malunion, including limping 1 year (very low certainty).
1 finding from 1 review
Intervention not reported
Pain (0 to 40: no pain) · individuals more than 18 years old with distal tibial metaphyseal fractures
It is very uncertain whether the intervention changes pain (0 to 40: no pain) (very low certainty).
1 finding from 1 review
Intervention not reported
Wound complications including superficial/deep wound infection and osteomyelitis 1 year · individuals more than 18 years old with distal tibial metaphyseal fractures
It is very uncertain whether the intervention changes wound complications including superficial/deep wound infection and… (very low certainty).
1 finding from 1 review
Intervention not reported
Fracture union 1 year · individuals more than 18 years old with distal tibial metaphyseal fractures
It is very uncertain whether the intervention changes fracture union 1 year (very low certainty).
1 finding from 1 review
VISA‐A (score 0 to 100; 100 = no problems) After 3 months (6 to 12 months) · individuals with an investigator‐reported diagnosis of Achilles tendinopathy (or related terminology, e.g. tendinitis). We excluded trials…
Summary of findings: Injection therapies showed no clear difference in VISA‐A (score 0 to 100; 100 = no problems) At 6 weeks compared with placebo or no injection control (low certainty).
3 findings from 1 review
MD 0.79
5 studies · 200 participants
Low
no estimate extracted
5 studies · 189 participants
Low
MD 0.14
3 studies · 132 participants
Low
Adverse events At final · individuals with an investigator‐reported diagnosis of Achilles tendinopathy (or related terminology, e.g. tendinitis). We excluded trials…
It is very uncertain whether summary of findings: Injection therapies changes adverse events At final compared with placebo or no injection control (very low certainty).
1 finding from 1 review